Procept (PRCT): 50% rise on high volume. Why?

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Procept (PRCT): 50% rise on high volume. Why?

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
455	2	0	PRCT

Emcee: Lee M. Davidson	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
155	No company mentioned. Only said "The corresponding author for this study	Douglas	-	5/6/1997
154	What company is this refering to?	Gerald Thomas	-	5/6/1997
153	Microbicides, AIDS Weekly Plus, May 5, 1997, Journal Article Summaries, p. 39	Douglas	-	5/6/1997
152	FOUND ANOTHER REFERENCE TO PRO 2000 IN THE 04/21/97 EDITION OF DRUG TOPICS (COP	Douglas	-	5/3/1997
151	Found it. ML Laboratories of Liverpool, England owns D2. ML's own antivir	Douglas	-	4/27/1997
150	The Terrence Higgins Trust in England has a two page briefing on microbicides (	Douglas	-	4/26/1997
149	SHORT INTEREST _________04/15/97____03/14/97___%CHANGE______AVG DAILY VOLUME P	Douglas	-	4/25/1997
148	The Cameroon results would give you that impression. I went back to the press	Douglas	-	4/25/1997
147	I might be missing something but if advantage 24 uses nonoxynol-9 and that has	Gerald Thomas	-	4/24/1997
146	Was the company Columbia Laboratories (American Stock Exchange "COB")	Douglas	-	4/24/1997
145	CBS Radio out of N.Y. this morning had a block of time on Microbicides and how	Gerald Thomas	-	4/24/1997
144	I used my Schwab 500 Research Line to obtain a company report for Procept. It	Douglas	-	4/23/1997
143	Interesting information. As with any other business, there is usually lots of c	Trumptown	-	4/23/1997
142	A one year old press release from FHI mentions what promising candidates scient	Douglas	-	4/23/1997
141	Zacks reported that Procept is expected to report earnings for the fiscal quart	Douglas	-	4/23/1997
140	The form PRE 14A showed the beneficial owners of 5% or more as: Aeneas Venture	Douglas	-	4/23/1997
139	I didn't get the letter... but if true about discussions of corporate inves	Gerald Thomas	-	4/22/1997
138	I'm surprised there is a large short position at these low prices. I think	Trumptown	-	4/22/1997
137	Stankie, We got a little pop today! Procept up 19.23% to 31/32 with 111,600 s	Douglas	-	4/21/1997
136	Doug, I believe anything in an IRA account is tax sheltered until it is withdr	Trumptown	-	4/21/1997
135	My guess would be public companies, since they use the word pharmaceutical.	Douglas	-	4/19/1997
134	I wonder if they mean public company partners or "sponsers such as NIH&quo	Gerald Thomas	-	4/19/1997
133	I received a letter from the President and CEO of Procept, Mr. Stanley C. Erck	Douglas	-	4/19/1997
132	Procept's Annual Meeting of Stockholders is June 16, 1997. The meeting wil	Douglas	-	4/19/1997
131	I was responding that they did do animal studies just to see if there was a ski	Gerald Thomas	-	4/18/1997

Go to reply# or date (mm/dd/yy):